MSB 7.69% $1.19 mesoblast limited

Cell Therapy News/Articles, page-16882

  1. 15,454 Posts.
    lightbulb Created with Sketch. 5535
    The Annual Financial report suggested that the meetings for "Chronic Heart Failure"

    What you mean the Annual Report that hasn't even ben released yet for 2023 and is due later this month ?

    As per usual your post comes with no references / screenshots / page numbers to support what you are claiming .... do point us to what document this is stated in and perhaps a page number won't you because we know it isn't the 2023 Annual Report ?


    upload_2023-10-2_11-10-5.png
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.